Kelly MacDonald - 10 Feb 2022 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
SVP and CFO
Signature
/s/ Kelly MacDonald
Issuer symbol
DVAX
Transactions as of
10 Feb 2022
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 20:09:35 UTC
Next filing
21 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Stock Option (Right to Buy) Award $0 +90,500 $0.000000 90,500 10 Feb 2022 Common Stock 90,500 $12.74 Direct F1
transaction DVAX Restricted Stock Unit Award +16,000 16,000 10 Feb 2022 Common Stock 16,000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 10, 2022, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
F2 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022